Jci_page_head_homepage_01 Jci_page_head_homepage_02
Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay
Published in Volume 116, Issue 12
J Clin Invest. 2006; 116(12):3258–3265 doi:10.1172/JCI29602
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
IGRP206–214 tetramer–positive CD8+ T cell numbers in peripheral blood and spleens of NOD and NOD-PI mice.

(A and B) Percentage of IGRP206–214-positive CD8+ T cells within (A) peripheral blood and (B) spleen. Data (mean ± SEM) are from mice 8 weeks (n = 8), 12 weeks (n = 12) and 15 weeks of age (n = 12). P < 0.005, NOD versus NOD-PI in peripheral blood at 12 weeks; P < 0.001, NOD versus NOD-PI in peripheral blood at 15 weeks; P < 0.02, NOD versus NOD-PI in spleen at 15 weeks. (C) Representative tetramer staining patterns. The numbers within dot plots indicate percentages of tetramer-positive CD8+ T cells.